In addition to DNA microarrays such as Affymetrix' Gene Chip products, the companies make instruments that sequence the genomes of living things, and develop tests for individual genetic variations.

Affymetrix is a California-based company that manufactures DNA microarrays called GeneChip, which are used by researchers to scan a biological sample for the presence of particular genes.

The microarray was designed by the US Food and Drug Administration's Center for Food Safety and Applied Nutrition (CFSAN) and built by Affymetrix. Thermo Fisher will significantly extend the ...

Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since the early 1990s, has grown to become much more than a microarray innovator. Through ...

April 8, 2013 Ingenuity Systems and Affymetrix will be co-promoting Ingenuity® iReport™ with Affymetrix’ expression microarray products to help eliminate a bottleneck for researchers working ...

Affymetrix is pairing with Singapore's PathGEN Dx to develop a kit that will detect more than 70,000 viral and bacterial genomes. | Affymetrix is pairing with Singapore's PathGEN Dx to develop a ...

Genetic products maker Affymetrix (NasdaqGS: AFFX - News) has inked a Memorandum of Understanding (“MOU”) with leading genomics center “BGI” to co-develop and commercialize microarrays for ...

Biotech Affymetrix and BGI Enter Strategic Collaboration to Co-Develop and Commercialize Genomic Microarrays for the Agricultural Jan 13, 2012 9:21am Biotech ...

Affymetrix' product categories include: microarray solutions, quantitative assays, PCR, molecular biology enzymes, molecular biology kits and reagents, biochemicals, detergents and lipids, etc.

The FDA clears Affymetrix Gene Profiling Reagents as gene expression accessories to its GeneChip® Microarray Instrument System for IVD use, becomes fi ...

SANTA CLARA, Calif.-- (BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX - News) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as ...